Rapid diagnostics continue transforming healthcare delivery worldwide, fueled by aging populations, decentralized care models, technological converge ...

Targeting de novo purine biosynthesis for tuberculosis treatment The validation of inhibitors targeting PurF, a novel drug target for tuberculosis drug discovery, is described. Dirk A. Lamprecht ...

BASEL, Switzerland I July 02, 2025 I BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of ...